Table 1 Antibiotic susceptibility of three XDR P. aeruginosa collected from the patient during the clinical course
Antibiotics | MICs (mg/L) | ||||
|---|---|---|---|---|---|
Endotracheal secretion samples | Abdominal tissue sample | ||||
hospital day 13 | hospital day 17 | hospital day 27 | |||
ISOLATE 1 | ISOLATE 2 | ISOLATE 3 | |||
Cefepime | > 64 | > 64 | > 64 | ||
Cefepime/zidebactam | 16 | 16 | 16 | ||
Ceftazidime | > 64 | > 64 | > 64 | ||
Ceftazidime/avibactam | > 64 | > 64 | > 64 | ||
Imipenem | > 64 | > 64 | > 64 | ||
Imipenem/relebactam | > 64 | > 64 | > 64 | ||
Ceftolozane/tazobactam | > 64 | > 64 | > 64 | ||
Piperacillin/tazobactam | > 64 | > 64 | > 64 | ||
Meropenem | > 64 | > 64 | > 64 | ||
Amikacin | > 64 | > 64 | > 64 | ||
Levofloxacin | > 64 | > 64 | > 64 | ||
Fosfomycin | > 256 | > 256 | > 256 | ||
Colistin | 0.25 | 0.25 | 0.25 | ||
Polymyxin B | 0.12 | 0.25 | 0.25 | ||
Imipenem + EDTA | 16 | 16 | 16 | ||
Ceftazidime/avibactam + EDTA | 16 | 16 | 16 | ||